KerrII B. Anderson - Aug 7, 2024 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kerrii B. Anderson
Stock symbol
LH
Transactions as of
Aug 7, 2024
Transactions value $
-$225,000
Form type
4
Date filed
8/9/2024, 10:16 AM
Previous filing
Jul 9, 2024
Next filing
Sep 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Sale -$93.2K -414 -2.63% $225.00 15.3K Aug 7, 2024 Direct F1
transaction LH Common Stock Sale -$132K -586 -3.83% $225.00 14.7K Aug 8, 2024 Direct F1
holding LH Common Stock 144 Aug 7, 2024 By Alexa M. Anderson Separate Trust
holding LH Common Stock 144 Aug 7, 2024 By Cameron Taff Anderson Separate Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Remarks:

On May 17, 2024, Labcorp Holdings Inc. ("LHI") became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.